Article citationsMore>>

Rai, D.K., Yurgelonis, I., Mcmonagle, P., Rothan, H., AHao, L., Gribenko, A. et al. (2021) Nirmatrelvir, an Orally Active Mpro Inhibitor, Is a Potent Inhibitor of SARS-CoV-2 Variants of Concern. BioRxiv.
https://doi.org/10.1101/2022.01.17.476644

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top